Related Experiment Video
Updated: Jun 24, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Diabetes and Dyslipidemia Screening in Pediatric Practice
Jordyn Huston1, Deepti Sudhakar2, Poornaashri Malarvannan1
1Department of Pediatrics, Saint Louis University School of Medicine, St. Louis, Missouri.
Insights
Childhood diabetes and hyperlipidemia are rising, increasing long-term health risks. Early screening and treatment are crucial for preventing serious complications in pediatric patients.
Area of Science:
- Pediatrics
- Endocrinology
- Public Health
Background:
- Rising incidence of pediatric diabetes and hyperlipidemia presents a significant public health concern.
- These metabolic conditions in children are linked to increased risks of macrovascular and microvascular complications.
- Early detection and intervention are vital to mitigate long-term morbidity and mortality.
Purpose of the Study:
- To summarize current screening guidelines for diabetes in pediatric patients.
- To outline current screening guidelines for hyperlipidemia in pediatric patients.
- To emphasize the importance of early detection for managing pediatric metabolic diseases.
Main Methods:
- Review of current clinical practice guidelines for pediatric diabetes screening.
- Analysis of current clinical practice guidelines for pediatric hyperlipidemia screening.
- Synthesis of recommendations for screening protocols in pediatric populations.
Main Results:
- Guidelines emphasize age-appropriate screening for diabetes based on risk factors.
- Recommendations for hyperlipidemia screening include routine checks and risk-based assessments.
- The importance of consistent screening protocols for early diagnosis is highlighted.
Conclusions:
- Implementing current screening guidelines can lead to earlier diagnosis of diabetes and hyperlipidemia in children.
- Early management of these conditions in pediatric patients is essential for reducing future health risks.
- Pediatric screening is a critical component of preventative healthcare for metabolic disorders.
Abstract:
The incidence of diabetes and hyperlipidemia are increasing at rapid rates in children. These conditions are associated with increased risk of macrovascular and microvascular complications causing major morbidity and mortality later in life. Early diagnosis and treatment can reduce the lifelong risk of complications from these diseases, exemplifying the importance of screening in the pediatric population. The following article presents a summary of the current guidelines for diabetes and hyperlipidemia screening in pediatric patients.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Lipids: Dietary Sources and Requirements

